201 related articles for article (PubMed ID: 34521295)
1. PAI-1 Polymorphisms Have Significant Associations With Cancer Risk, Especially Feminine Cancer.
Wang J; Peng Y; Guo H; Li C
Technol Cancer Res Treat; 2021; 20():15330338211037813. PubMed ID: 34521295
[TBL] [Abstract][Full Text] [Related]
2. Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility: A meta-analysis.
Zhang X; Gao B; Xu B
Medicine (Baltimore); 2020 Dec; 99(50):e23660. PubMed ID: 33327353
[TBL] [Abstract][Full Text] [Related]
3. The roles of PAI-1 gene polymorphisms in atherosclerotic diseases: A systematic review and meta-analysis involving 149,908 subjects.
Liu Y; Cheng J; Guo X; Mo J; Gao B; Zhou H; Wu Y; Li Z
Gene; 2018 Oct; 673():167-173. PubMed ID: 29908999
[TBL] [Abstract][Full Text] [Related]
4. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.
Wang J; Wang C; Chen N; Shu C; Guo X; He Y; Zhou Y
Thromb Res; 2014 Dec; 134(6):1241-8. PubMed ID: 25450536
[TBL] [Abstract][Full Text] [Related]
5. Association between the SERPINE1 (PAI-1) 4G/5G insertion/deletion promoter polymorphism (rs1799889) and pre-eclampsia: a systematic review and meta-analysis.
Zhao L; Bracken MB; Dewan AT; Chen S
Mol Hum Reprod; 2013 Mar; 19(3):136-43. PubMed ID: 23180602
[TBL] [Abstract][Full Text] [Related]
6. PAI-1 4G/5G polymorphism contributes to cancer susceptibility: evidence from meta-analysis.
Wang S; Cao Q; Wang X; Li B; Tang M; Yuan W; Fang J; Qian J; Qin C; Zhang W
PLoS One; 2013; 8(2):e56797. PubMed ID: 23437240
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review.
Zhang Q; Jin Y; Li X; Peng X; Peng N; Song J; Xu M
Vasa; 2020 Mar; 49(2):141-146. PubMed ID: 31920171
[No Abstract] [Full Text] [Related]
8. Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss.
Li X; Liu Y; Zhang R; Tan J; Chen L; Liu Y
Med Sci Monit; 2015 Apr; 21():1051-6. PubMed ID: 25862335
[TBL] [Abstract][Full Text] [Related]
9. Association between plasminogen activator inhibitor-1 -675 4G/5G polymorphism and sepsis: a meta-analysis.
Li L; Nie W; Zhou H; Yuan W; Li W; Huang W
PLoS One; 2013; 8(1):e54883. PubMed ID: 23382992
[TBL] [Abstract][Full Text] [Related]
10. Correlation between
Geng B; Li S; Zhou J; Feng G
Phlebology; 2020 Aug; 35(7):472-479. PubMed ID: 31948344
[TBL] [Abstract][Full Text] [Related]
11. Association Between Plasminogen Activator Inhibitor-1 Genetic Polymorphisms and Stroke Susceptibility.
Hu X; Zan X; Xie Z; Li Y; Lin S; Li H; You C
Mol Neurobiol; 2017 Jan; 54(1):328-341. PubMed ID: 26742513
[TBL] [Abstract][Full Text] [Related]
12. PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis.
Xu X; Xie Y; Lin Y; Xu X; Zhu Y; Mao Y; Hu Z; Wu J; Chen H; Zheng X; Qin J; Xie L
Exp Ther Med; 2012 Dec; 4(6):1127-1133. PubMed ID: 23226787
[TBL] [Abstract][Full Text] [Related]
13. Association of PAI-1 rs1799889 Polymorphism with Susceptibility to Ischemic Stroke: a Huge Meta-Analysis based on 44 Studies.
Jafari M; Jarahzadeh MH; Dastgheib SA; Seifi-Shalamzari N; Raee-Ezzabadi A; Sadeghizadeh-Yazdi J; Akbarian E; Neamatzadeh H
Acta Medica (Hradec Kralove); 2020; 63(1):31-42. PubMed ID: 32422114
[TBL] [Abstract][Full Text] [Related]
14. The -675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysis.
Nie W; Li B; Xiu QY
PLoS One; 2012; 7(3):e34385. PubMed ID: 22479620
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism of the plasminogen activator inhibitor-1 is associated with an increased risk of endometrial cancer.
Su CK; Yeh KT; Yeh CB; Wang PH; Ho ES; Chou MC; Liu KC; Yang SF; Yi YC
J Surg Oncol; 2011 Dec; 104(7):755-9. PubMed ID: 21761413
[TBL] [Abstract][Full Text] [Related]
16. Association between Five Common Plasminogen Activator Inhibitor-1 (
Oh J; An HJ; Kim JO; Jun HH; Kim WR; Kim EJ; Oh D; Kim JW; Kim NK
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570732
[TBL] [Abstract][Full Text] [Related]
17. Association between PAI-1 4G/5G polymorphism and diabetic nephropathy: a meta-analysis in the Chinese population.
Gao WF; Guo YB; Bai Y; Ding XY; Yan YJ; Wu ZQ
Int Urol Nephrol; 2016 Sep; 48(9):1483-9. PubMed ID: 27272255
[TBL] [Abstract][Full Text] [Related]
18. PAI-1 Gene Polymorphism Was Associated with an Increased Risk of Allergic Diseases: Evidence from a Meta-Analysis of 14 Case-Control Studies.
Zheng L; Li X; Song Q; Hou C; Chen X; Li B
Int Arch Allergy Immunol; 2019; 180(4):255-263. PubMed ID: 31574527
[TBL] [Abstract][Full Text] [Related]
19. The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer.
Yıldırım ME; Karakuş S; Kurtulgan HK; Kılıçgün H; Erşan S; Bakır S
Biochem Genet; 2017 Aug; 55(4):314-321. PubMed ID: 28303356
[TBL] [Abstract][Full Text] [Related]
20. Significant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral head.
Kim H; Cho C; Cho Y; Cho S; Yoon K; Kim K
BMC Musculoskelet Disord; 2011 Jul; 12():160. PubMed ID: 21752301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
